AsclepiX Therapeutics logo

AsclepiX Therapeutics Funding & Investors

AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maint... Read more

asclepix.com

Total Amount Raised: $50,000,000

AsclepiX Therapeutics Funding Rounds

  • Series A

    $10,000,000

    Series A Investors

    Hibiscus Capital Management
    Rapha Capital Management
    Perceptive Advisors
  • Series A

    $35,000,000

    Series A Investors

    Barer & Son Capital
    Rapha Capital Management
    Perceptive Advisors
  • Convertible Note

    $5,000,000

    Convertible Note Investors

    Barer & Son Capital
    Piedmont Capital Partners
    Rapha Capital Management
    Salem Partners
    TEDCO
Funding info provided by Diffbot.